title: UK guidelines for the systemic treatment of renal cell carcinoma.
abstract: There have been recent significant improvements in treatment options for patients with advanced renal cell carcinoma. This article presents UK consensus guidelines on the use of systemic therapies for this poor prognosis disease.
authors.affiliation: Mount Vernon Cancer Centre, Northwood, Middlesex.
authors.forename: Paul
authors.initials: P
authors.lastname: Nathan
authors.forename: John
authors.initials: J
authors.lastname: Wagstaff
authors.forename: Emilio
authors.initials: E
authors.lastname: Porfiri
authors.forename: Tom
authors.initials: T
authors.lastname: Powles
authors.forename: Tim
authors.initials: T
authors.lastname: Eisen
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002292:Carcinoma, Renal Cell / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D019317:Evidence-Based Medicine; D006801:Humans; D007680:Kidney Neoplasms / Q000188:drug therapy*; D017410:Practice Guidelines as Topic; D011379:Prognosis; D006113:United Kingdom
chemical_list: D000970:Antineoplastic Agents